Hyperinsulinemia in Obesity, Inflammation, and Cancer

Anni M.Y. Zhang; Elizabeth A. Wellberg; Janel L. Kopp; James D. Johnson

doi:10.4093/dmj.2021.0131

Diabetes Metab J > Volume 45(4); 2021 > Article

Zhang, Wellberg, Kopp, and Johnson: Hyperinsulinemia in Obesity, Inflammation, and Cancer

Erratum

Diabetes Metab J. 2021;45(4):622-622.

Published online: July 30, 2021

DOI: https://doi.org/10.4093/dmj.2021.0131

Hyperinsulinemia in Obesity, Inflammation, and Cancer

Anni M.Y. Zhang¹, Elizabeth A. Wellberg², Janel L. Kopp¹, James D. Johnson¹

¹Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, BC, Canada

²Department of Pathology, University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Harold Hamm Diabetes Center, Oklahoma City, OK, USA

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

This corrects the article "Hyperinsulinemia in Obesity, Inflammation, and Cancer" in Volume 45 on page 285.

Diabetes Metab J 2021;45:285-311. https://doi.org/10.4093/dmj.2020.0250

In the article cited above, there was a spelling error in the Fig. 1. In the middle of Fig. 1, “obsity” was misspelled. The correct word is “obesity.”

We apologize for any inconvenience that this may have caused.

Fig. 1.

Trade-offs with insufficient and excessive circulating insulin levels.

TOOLS

METRICS

0 Crossref
0 Scopus
331 View
18 Download

Related articles

Hyperinsulinemia in Obesity, Inflammation, and Cancer2021 May;45(3)

Chemerin: A Novel Link between Inflammation and Atherosclerosis?2011 June;35(3)

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr